ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1341

Physical Function Across Age in Patients With Rheumatoid Arthritis and Population Controls: A Cross-Sectional Study of Four Performance Measures

Saskia Truijen1, Annelies Boonen1, Sofia Ramiro2 and Marloes van Onna1, 1Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands, 2Leiden University Medical Center, Bunde, Netherlands

Meeting: ACR Convergence 2025

Keywords: Aging, Epidemiology, grip strength, physical function, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) may accelerate age-related functional decline compared to the general population. This study aimed to examine whether four performance measures of physical function differ between older patients with RA and population controls, and whether this decline is stronger with increasing age in patients with RA.

Methods: Cross-sectional data of patients with RA and population controls without inflammatory rheumatic disease aged 55–85 years from the STudying Aging in Rheumatoid arthritis (STAR) study was used. Physical function was assessed using four measures. All participants completed the self-reported Cochin hand functional disability questionnaire (18 items; 0=no functional hand disability, 90=maximal disability; score ≥1 = impaired). In a subpopulation, additional physical measurements were conducted: grip strength of the dominant hand measured with a dynamometer (kg; fulfilling sex- and BMI-specific Fried frailty criteria = impaired), gait speed using the four-meter walk test (< 0.8 m/s = impaired), and the Five Times Sit-to-Stand Test (FTSST) ( >15.0s = impaired). Correlations between age and outcomes of physical function were explored separately for RA patients and controls and visualized using scatter plots. Linear and logistic regressions assessed age and sex adjusted associations between group (RA vs. control) and outcome, and the interaction age*group. Due to a left-skewed distribution, Cochin scores were only analyzed using logistic regression (≥1 vs. 0).

Results: A total of 416 persons were included: 197 patients with RA (mean age 68 ± 7, 62% women) and 209 population controls (mean age 68 ± 7, 60% women). The subpopulation consisted of 168 persons: 78 patients with RA (mean age 67 ± 8, 51% women) and 90 controls (mean age 68 ± 7, 58% women). Age correlated moderately with gait speed in controls and handgrip strength in female controls, but correlated weakly for all other comparisons (Figure 1A-D). For self-reported handfunction, RA patients were more likely to report a functional disability (score ≥1) (OR=4.9, 95%CI: 3.2–7.6) (Table 1). For hand grip strength, patients with RA had lower handgrip strength (β=-4.7, 95%CI: -7.7 to -1.7) and were more likely to meet the Fried criteria for low grip strength (OR=2.5, 95%CI: 1.2–5.1), as compared to controls. For gait speed and FTSST, no associations with RA were observed. A significant interaction between age and group was only observed for the Cochin scale, however, after stratification this was not considered clinically relevant.

Conclusion: These findings suggest that while RA leads to lower physical functioning compared to controls, this effect does not differ across age. Functional decline in RA may be more disease-specific than age-driven, highlighting the importance of early management of RA. The results may also indicate that current RA treatment may be effective in limiting excessive functional decline later in life, by reducing cumulative joint damage over time.

Supporting image 1Figure 1.

A) The Cochin hand function scale by age, stratified for population controls (n=209; r=0.05) and patients with RA (n=197; r=0.11)

B) Observed dominant handgrip strength (kg) by age, stratified for population controls (men: n=38; r=-0.35, women: n=52; r=-0.48) and patients with RA (men: n=39; r=-0.26, women: n=38; r=-0.45)

C) Gait speed (m/s) by age, stratified for population controls (n=90; r=-0.50) and patients with RA (n=78; r=-0.32)

D) Five times sit-to-stand test (s) by age, stratified for population controls (n=90; r=0.23) and patients with RA (n=78; r=-0.08)

Supporting image 2


Disclosures: S. Truijen: None; A. Boonen: AbbVie/Abbott, 5, Alfasigma, 2, Celgene, 5, Eli Lilly, 2, Novartis, 2, Sandoz, 2, UCB, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5; M. van Onna: Alfasigma, 2, Novartis, 2, Pfizer, 2, 5, ReumaNederland, 5.

To cite this abstract in AMA style:

Truijen S, Boonen A, Ramiro S, van Onna M. Physical Function Across Age in Patients With Rheumatoid Arthritis and Population Controls: A Cross-Sectional Study of Four Performance Measures [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/physical-function-across-age-in-patients-with-rheumatoid-arthritis-and-population-controls-a-cross-sectional-study-of-four-performance-measures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/physical-function-across-age-in-patients-with-rheumatoid-arthritis-and-population-controls-a-cross-sectional-study-of-four-performance-measures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology